2. Academic Validation
  3. Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6

Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6

  • ACS Med Chem Lett. 2026 Mar 3;17(3):634-636. doi: 10.1021/acsmedchemlett.6c00096.
Yinlong Li 1,  Steven H Liang 1 2
Affiliations

Affiliations

  • 1 Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
  • 2 Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States.
PMID: 41847644 DOI: 10.1021/acsmedchemlett.6c00096
Abstract

This patent highlight describes the synthesis and assessment of a series of new inverse agonists targeting G protein-coupled receptor 6 (GPR6) based on pyridopyrazine analogs. It details their chemical synthesis, characterization, and biological activity assays.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z